Please help me to understand .

Well, the name of the company alone would have made me suspicious...

Cingulates are a class of animals. It includes horses, cows, and deer. Basically it's animals with hooves.

Why would you name a drug company something like that??

Okay, wait a minute

I'm thinking of ungulates

Nevermind

Wasn't cingulate the name of a wireless carrier back in the 90s?

Or maybe that was Cingular

I thought cingulate was an asthma medication

Okay, maybe I'm thinking of Singulair

nevermind
 
cashclay said:
Recently I was in a stock called CING . They were in phase 3 clinical trials for their new ADHD drug. Phase 3 was postive results . The resistance was at around 2 usd. However the stock, also being a low float, was only able to manage to get around the 1.60ish area before now crashing down to .70 cents perhaps the lowest point its ever been. Before the news it was heavily shorted also.
I sold my shares before all this happened but Im so confused. Isnt phase 3 trials being positive a good thing for the company and its stock price??? And I could also understand if it came back down to its orginal area before the news which was at .90 ish but now its trading at .70 . So why did this happen to a company with such a low float and such amazing news in an wealth generating industry?

Someone said its because the company was selling its shares ATM to raise some capital for its adolescents phase 3 trials... The adult phase 3 trials was the one with positive news... Is this also a reason as well?

Sorry I am newb trying to learn the market. Any assistance or help would be of great value.
More...

Is it possible the news is not as amazing or pro biotech investors think different? I know recently ORIC and CRBU did private placements and their stocks hauled ass! You can tell the quality of dilution and news by price. Look at the great news VBIV released in AH, stock jumped $2.4 to $4.50. Minutes later they announced the Flood of shares and warrants. Stock opened at $1.08 next day but the news was so good?
 
There is also the possibility that you are correct and you just exited on a "sell the news" hiccup. You might want to think about what would you prompt you re-enter. Armchair quarterbacking penny stocks is pretty easy. Pure VC has a very low success rate, but monstrous returns when you are correct.
FDA approval, if it ever becomes reality, would be huge.
 
Last edited:
cashclay said:
Recently I was in a stock called CING . They were in phase 3 clinical trials for their new ADHD drug. Phase 3 was postive results . The resistance was at around 2 usd. However the stock, also being a low float, was only able to manage to get around the 1.60ish area before now crashing down to .70 cents perhaps the lowest point its ever been. Before the news it was heavily shorted also.
I sold my shares before all this happened but Im so confused. Isnt phase 3 trials being positive a good thing for the company and its stock price??? And I could also understand if it came back down to its orginal area before the news which was at .90 ish but now its trading at .70 . So why did this happen to a company with such a low float and such amazing news in an wealth generating industry?

Someone said its because the company was selling its shares ATM to raise some capital for its adolescents phase 3 trials... The adult phase 3 trials was the one with positive news... Is this also a reason as well?

Sorry I am newb trying to learn the market. Any assistance or help would be of great value.
More...

A biotech company with no product & no revenue is a lottery ticket.
How do you value a lottery ticket?
Is $1 cheap or expensive? Is it cheap at $0.30? Money losing company with NO product.
How much investors are willing to pay depends upon how likely the product will get approved then how big is the market they're addressing with the product.
If approved, what will it cost to produce & market the product? Can they sell enough to pay for costs?
Most biotech without a product is a gamble & not an investment so play with small $$.
Personally, I've lost more than made in biotech so mostly avoid now.
 
cashclay said:
Recently I was in a stock called CING . They were in phase 3 clinical trials for their new ADHD drug. Phase 3 was postive results . The resistance was at around 2 usd. However the stock, also being a low float, was only able to manage to get around the 1.60ish area before now crashing down to .70 cents perhaps the lowest point its ever been. Before the news it was heavily shorted also.
I sold my shares before all this happened but Im so confused. Isnt phase 3 trials being positive a good thing for the company and its stock price??? And I could also understand if it came back down to its orginal area before the news which was at .90 ish but now its trading at .70 . So why did this happen to a company with such a low float and such amazing news in an wealth generating industry?
Someone said its because the company was selling its shares ATM to raise some capital for its adolescents phase 3 trials... The adult phase 3 trials was the one with positive news... Is this also a reason as well?
Sorry I am newb trying to learn the market. Any assistance or help would be of great value.
More...
I'll attempt to assist.
As a trader you can fall in love or be interested in a stock for several reasons.
You may like the story, you may like the share chart, you may like the fundamentals.
But the bottom line for a trader is they think they can make money, so they buy in because they believe for a number of reasons share price will rise and you can sell later and become rich.

As a noob you have to understand one thing and one thing only, there are a huge number of very smart people involved in trading, not only traders but coders, bosses, employees, computer whiz kids, gamers etc.

If the share price is rising or falling, the news, the fundamentals, etc doesn't mean a lot, shares can rise on bad news and fall on good news.
The people in control of price control price to manipulate it, allowing it to rise to offload and fall to get a better bargain.

CING stock is falling, it has terrible turnover, no one is much interested in it other than perhaps shorters.
CING suffers from low liquidity and high volatility.
If you enjoy pain, then go ahead and attempt to trade this POS.
It's a penny stock pump and dumper and a lousy one at that too.
If you read any news articles about this stock beware the news is probably slanted heavily to suck in noobs.
Don't believe anything other than about 5% of what they spout on about on penny stocks.
From trading originally at $5 to now 80c in 20 months, there is nothing quality in this company, certainly not for an investor or long trader.
 
tomkat22 said:
The world of penny stocks is rife with pump and dump scams,and other nefarious activities. That's why I dont mess with them. And you said resistance was 2.00,on what, a 10 year timeframe?! It hasn't traded over 1.17 in several months. And I noticed it recently traded only 9000 shares ALL DAY. How in the world are you going to make rhyme or reason out of a stock like that?
More...
it’s not trading on the otc. it’s nasdaq stock
 
Overnight said:
"...Assuming positive clinical results from the Phase 3 trials, Cingulate plans to submit a New Drug Application (NDA) for CTx-1301 in mid-2024 under the Section 505(b)(2) pathway."

Wait until around X-Mas for it to REALLY bottom. Then you won't care about why it dropped to .70 when you can get it for a quarter.

Because that sure looks like the current trajectory...

View attachment 318746
More...
%%
Good points\ on that down trending chart.
I'll use your chart\200+ days of data + still going down.
State Street Corp has 3.8% of MSFT;
but has or had 0.38%,of CING but its valued or was valued @$36k.
I have picked up pennies in my path, but not as a goal with low volume stocks on Wall Street.
Every now + then people find gold coin treasure in a corn field. NOT usually:caution::caution:
Gold + silver tend to underperform stock market average anyway.Live + learn.
 
cashclay said:
Recently I was in a stock called CING . They were in phase 3 clinical trials for their new ADHD drug. Phase 3 was postive results . The resistance was at around 2 usd. However the stock, also being a low float, was only able to manage to get around the 1.60ish area before now crashing down to .70 cents perhaps the lowest point its ever been. Before the news it was heavily shorted also.
I sold my shares before all this happened but Im so confused. Isnt phase 3 trials being positive a good thing for the company and its stock price??? And I could also understand if it came back down to its orginal area before the news which was at .90 ish but now its trading at .70 . So why did this happen to a company with such a low float and such amazing news in an wealth generating industry?

Someone said its because the company was selling its shares ATM to raise some capital for its adolescents phase 3 trials... The adult phase 3 trials was the one with positive news... Is this also a reason as well?

Sorry I am newb trying to learn the market. Any assistance or help would be of great value.
More...

Stick to non-penny-stocks or ETFs with reasonable volume. Or are TSLA, NVDA, FNGU etc not good enough for you?
 
You must log in or register to reply here.
Back
Top